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ABSTRACT
The regulated head-to-tail expression of Hox genes provides a
coordinate system for the activation of specific programmes of cell
differentiation according to axial level. Recent work indicates that Hox
expression can be regulated via RNA processing but the underlying
mechanisms and biological significance of this form of regulation
remain poorly understood. Here we explore these issues within the
developing Drosophila central nervous system (CNS). We show that
the pan-neural RNA-binding protein (RBP) ELAV (Hu antigen)
regulates the RNA processing patterns of the Hox gene
Ultrabithorax (Ubx) within the embryonic CNS. Using a combination
of biochemical, genetic and imaging approaches we demonstrate that
ELAV binds to discrete elements withinUbxRNAs and that its genetic
removal reduces Ubx protein expression in the CNS leading to the
respecification of cellular subroutines under Ubx control, thus
defining for the first time a specific cellular role of ELAV within the
developing CNS. Artificial provision of ELAV in glial cells (a cell type
that lacks ELAV) promotes Ubx expression, suggesting that ELAV-
dependent regulation might contribute to cell type-specific Hox
expression patterns within the CNS. Finally, we note that
expression of abdominal A and Abdominal B is reduced in elav
mutant embryos, whereas other Hox genes (Antennapedia) are not
affected. Based on these results and the evolutionary conservation of
ELAV and Hox genes we propose that the modulation of Hox RNA
processing by ELAV serves to adapt the morphogenesis of the CNS
to axial level by regulating Hox expression and consequently
activating local programmes of neural differentiation.
KEY WORDS: Central nervous system, Drosophila, ELAV/Hu, Hox,
RNA-binding protein, RNA processing, Alternative polyadenylation
(APA), Alternative splicing, Segment-specific apoptosis
INTRODUCTION
The nervous system of vertebrates and invertebrates shows a
remarkable level of regionalisation along the anteroposterior (AP)
axis, so that the identity, arrangement and connectivity of nerve cells
change according to axial level (Arendt and Nubler-Jung, 1999;
Lumsden and Keynes, 1989; Lumsden and Krumlauf, 1996;
Reichert, 2002; Thor, 1995). At the molecular level, axial neural
specification relies centrally on the regulated expression of the Hox
genes, a group of evolutionarily conserved genes that encode a
family of homeodomain-containing transcription factors that
activate specific cell differentiation programmes in different parts
of the nervous system (McGinnis and Krumlauf, 1992; Alonso,
2002; Mallo and Alonso, 2013). An understanding of the molecular
mechanisms underlying Hox gene expression and function within
the CNS is thus crucial to decipher the ability of these genes to direct
pluripotent neural populations along different developmental routes.
Hox gene expression can be regulated at multiple levels through a
variety of transcriptional and post-transcriptional mechanisms
(Simon et al., 1990; Shimell et al., 1994; Alonso and Wilkins,
2005; Alonso, 2012;Mallo and Alonso, 2013). Previous work in our
laboratory and elsewhere has demonstrated that, in Drosophila,
several Hox transcripts undergo mRNA processing by alternative
splicing and alternative polyadenylation (Akam andMartinez-Arias,
1985; Kornfeld et al., 1989; Lopez and Hogness, 1991; O’Connor
et al., 1988; Reed et al., 2010; Thomsen et al., 2010), that these
processes affect Hox gene expression and function in a range of
developmental contexts (Mann and Hogness, 1990; Subramaniam
et al., 1994; Thomsen et al., 2010; Reed et al., 2010; de Navas et al.,
2011) and are evolutionarily conserved over large phylogenetic
distances (Bomze andLopez, 1994; Patraquim et al., 2011).Notably,
within the Drosophila embryonic CNS several Hox genes express
specific splicing and 30UTR isoforms (Thomsen et al., 2010),
suggesting that RNA processing might represent a control system
involved in fine-grain regulation of Hox expression within the CNS.
Nonetheless, the underlyingmechanisms and biological relevance of
Hox RNA processing within neural tissues remain largely unknown.
Here we apply a reverse genetics approach designed to detect
factors involved inHoxRNAprocessing, focusingongenes expressed
within the Drosophila embryonic CNS. As a gene model we use the
Hox gene Ultrabithorax (Ubx), as this is the system in which RNA
processing is understood in greatest detail (Hatton et al., 1998; Alonso
and Akam, 2003; de la Mata et al., 2003; Reed et al., 2010; Alonso,
2012; Mallo and Alonso, 2013). Our approach led us to identify the
pan-neural RNA-binding protein (RBP) ELAV (also known as Hu
antigen) (Robinow et al., 1988; Robinow and White, 1988; Good,
1995) as a key regulator of Ubx RNA processing, expression and
functionwithin theDrosophila embryonic CNS and to definewhat is,
to our knowledge, the first specific cellular role ofELAVduringneural
development. We discuss the implications of our findings for the
understanding of the molecular programmes controlling neural
differentiation along the head-to-tail axis of animals.
RESULTS
ELAV regulates Ubx RNA processing in the embryonic CNS
Embryos carrying a null mutation in the elav gene [elav5 mutants
(Yao et al., 1993)] produced patterns of Ubx alternative splicing
(AS) and alternative polyadenylation (APA) that were significantly
different from those found in wild-type embryos (Fig. 1A-H),Received 24 July 2013; Accepted 24 March 2014
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indicating thatDrosophila ELAV is necessary for normalUbx RNA
processing within the embryonic CNS. During normal embryonic
development, alternatively spliced forms of Ubx are produced in a
specific spatiotemporal pattern of expression: isoforms containing
both M1 and M2 exons (Ubx I, Fig. 1A,B) account for most of the
Ubx mRNAs expressed in epidermis and mesoderm, whereas
isoforms lacking M1 and/or M2 (Ubx II and IV, Fig. 1A,B) are most
abundant in neural cells (Artero et al., 1992). With regards to APA,
Ubx mRNA forms bearing short 30UTRs are dominant during
early and mid-embryogenesis, but later on in development (late
embryogenesis) the formation of long 30UTR forms becomes
predominant, especially in neural tissue (Akam andMartinez-Arias,
1985; Kornfeld et al., 1989; O’Connor et al., 1988; Lopez and
Hogness, 1991; Thomsen et al., 2010).
We examined Ubx RNA processing profiles using two
independent experimental approaches: RT-PCR and RNA in situ
hybridisations in dissected ventral nerve cords (i.e. oligo in situ
hybridisations) or in whole embryos (Fig. 1C-H). Remarkably, both
approaches were consistent in showing that, in elav5mutants at stage
16, Ubx splicing isoforms Ia and IVa were over- and under-
represented, respectively (Fig. 1C-E) (whereas isoform Ubx IIa
showed comparatively little change across genotypes). This analysis
also revealed an overall reduction in Ubx long 30UTR mRNAs
(Fig. 1F-H). Notably, we also observed that ectopic expression of
ELAV during gastrulation is sufficient to change the pattern of Ubx
APA by directing the formation of UbxmRNA forms carrying long
30UTRs that are typically observed only in the CNS (Fig. 1I) instead
of the shorter 30UTRs commonly expressed at this stage (Thomsen
et al., 2010). This indicates that ELAV is both necessary and
sufficient to reprogramme Ubx 30UTR RNA processing during
embryogenesis. At later stages (stage 16), when the majority of Ubx
mRNAs normally exhibit a long 30UTR (Thomsen et al., 2010),
overexpression of ELAV causes no detectable change, suggesting
that the system is likely to already be producing as much of the long
Ubx 30UTRs as it possibly can (supplementary material Fig. S2).
Altogether, these experiments demonstrate that ELAV is necessary
and sufficient to modify the RNA processing patterns of a
Drosophila Hox gene.
ELAV interacts with discrete elements within Ubx RNA
To determine the mechanisms that link ELAV expression level with
Ubx RNA processing events we explored the model that ELAV
exerts its effects via direct interaction with Ubx RNA. ELAV/Hu
proteins possess an RNA-binding unit bearing three RNA
recognition motifs that show high affinity for AU-rich elements
(Wang and Tanaka, 2001). Given that elav encodes an RBP we
Fig. 1. The RNA-binding protein ELAV regulates Hox RNA processing in the Drosophila CNS. (A,B) The Drosophila Ubx gene produces a spectrum of
RNA isoforms via alternative splicing (AS) and alternative polyadenylation (APA). Ubx AS isoforms differ from each other by the presence/absence of small
(micro) exons termedM1 and M2;Ubx APA leads to the formation of mRNAs bearing a long or short 30UTR. PAS1, polyadenylation site 1; PAS2, polyadenylation
site 2; 50E, 50 exon; 30E, 30 exon. 50 and 30 mRNA ends are indicated. (C,D) Molecular analysis ofUbx AS profiles in lateDrosophila embryos reveals that changes
in ELAV expression lead to a significant change in Ubx AS patterns, especially concerning Ubx isoforms Ia and IVa which are over-represented and under-
represented, respectively (arrows), in elav mutant (elav5) embryos. (E) Developmental expression analysis of specific Ubx splicing isoforms in dissected
embryonic ventral nerve cords (anterior is to the left) using oligo in situ hybridisation confirms that changes in ELAV expression lead to changes in the expression
level of Ubx splicing isoforms in the developing CNS. PS6, parasegment 6. (F,G) Molecular analysis of Ubx APA patterns shows that changes in ELAV level
lead to a significant change in the abundance of long and short 30UTR isoforms at late embryogenesis (n=3). CDS, coding sequence. Error bars indicate s.e.m.
**P<0.01 [Wilcoxon matched-pairs signed rank test (non-parametric t-test)]. (H,I) Mutation in the RBP ELAV leads to a reduction in the expression of long
30UTR forms of Ubx within the CNS of embryos (H). Notably, ectopic expression of ELAV at the germband extension stage (I) shows a clear increase in the
expression of long 30UTR isoforms of Ubx, indicating that ELAV is sufficient to induce a change in Ubx RNA processing in vivo.
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Fig. 2. See next page for caption.
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scanned Ubx RNA sequences for putative ELAV binding sites
(EBS). Bioinformatic analysis of the Ubx locus revealed the
existence of several EBSs (Fig. 2A; supplementary material Fig. S3
and legend). Remarkably, 16 Ubx EBSs were significantly
evolutionarily conserved across Drosophila species that evolved
independently from each other for over 60 million years, suggesting
a potential functional relevance of these sites (Fig. 2A).
To test the hypothesis that ELAV interacts with Ubx RNA in a
direct fashion, we determined to what extent ELAV was able to
interact with radioactively labelled Ubx RNAs in vitro (Fig. 2B-E).
We used two distinct experimental approaches: protein/RNA UV
crosslinking followed by RNase A treatment (Fig. 2B) and RNA
electrophoretic mobility shift assay (EMSA) (Fig. 2C-E). In both
biochemical approaches we tested ultraconserved EBSs (Fig. 2A)
using sequences derived from the previously described ELAV target
erect wing (ewg) as positive [ewg wild type (WT)] and negative
[ewg antisense (AS)] controls (Koushika et al., 2000; Soller and
White, 2003). Notably, analysis of those sites showing the highest
level of evolutionary conservation (supplementary material Fig. S3)
revealed, by means of these two independent experimental
approaches, that ELAV strongly interacts with Ubx RNAs directly
through high affinity binding to ultraconserved sites EBS3 and
EBS8, but very weakly with sites EBS13 and EBS16. Furthermore,
site-specific mutation of the predicted ELAV binding sequences
contained within EBS3 and EBS8 (supplementary material Fig. S3)
led to different patterns of ELAV binding to Ubx RNA (Fig. 2E):
EMSA using mutated versions of probes 3 and 8 showed reduced
binding activity and a change in the range of protein-RNA
complexes formed. These experiments also reveal the formation
of protein-RNA complexes, including multimerised forms of ELAV
on RNA (Fig. 2C,D). This has been observed previously in the
interaction of ELAV with ewg RNAs (Soller and White, 2005).
To determine the extent towhich ELAV-UbxRNA interactions take
place within the physiological environment of the developing embryo
we developed a series of RNA cross-linking and immunoprecipitation
(RNA-CLIP) assays using embryonic nuclear extracts (Fig. 2F). These
experiments confirmed that ELAV interacts with Ubx RNAs at EBS3
and EBS8 in normal tissue, while a negative control antibody (anti-
Tubulin) rendered a significantly lower level of Ubx RNA
precipitation (Fig. 2F). We conclude that our biochemical analysis
supports the model that ELAV interacts with Ubx RNAs directly via
sites in Ubx introns 1 and 3 (EBS3 and EBS8, respectively; see
Fig. 2A).
ELAV regulates Ubx expression levels within the CNS
To investigate the biological consequences of ELAV interactions
with Ubx during development we first sought to explore whether
these had an impact on Ubx expression. First, we examined the
extent to which the effects observed at the level of RNA processing
(Fig. 1C-H) were reflected at the protein level. Western blot analysis
of whole-embryo protein extracts produced fromwild type and elav5
mutants (stage 16) revealed that elav5 mutant embryos produce a
larger amount of Ubx Ia and reduced levels of Ubx IVa compared
with wild-type embryos, closely matching the ELAV-dependent
changes observed inUbxmRNA isoforms (Fig. 1C-H and Fig. 3B).
Interestingly, our western blot experiments also showed that elav5
mutants produced reduced levels of Ubx protein. Given that at this
point in development Ubx is also expressed in other tissues (e.g.
epidermis) we carried out a series of immunostainings to detect Ubx
protein expression exclusively in dissected ventral nerve cords
(Fig. 3A). These experiments showed that elav5 embryos produce
significantly less Ubx protein than their wild-type counterparts at
stage 16 (Fig. 3A,C). Heterozygous elavmutant embryos showed an
intermediate level of expression between homozygous mutants and
wild-type embryos (not shown). These data confirmed that ELAV
removal leads to a significant reduction in Ubx protein expression.
In principle, ELAV could exert its effects on protein expression at
multiple points, including Ubx mRNA synthesis, stability and/or the
translational process itself (Simone and Keene, 2013). Two
observations suggested that ELAV might be affecting Ubx RNA
processing during the transcription cycle. First, our data demonstrated
that ELAV is able to modify two aspects ofUbxRNA processing, i.e.
AS and APA, both of which occur co-transcriptionally (Di
Giammartino et al., 2011; Licatalosi and Darnell, 2010; Proudfoot,
2011). Second, our protein-RNA binding experiments (Fig. 2)
indicate that ELAV binds Ubx RNAs via interactions with elements
present in Ubx introns (see above), making it somewhat unlikely that
ELAVwould remain physically associated to the fully processedUbx
mRNA and act directly on the translational process. Based on these
considerations, we decided to test the hypothesis that ELAV exerts its
effects on Ubx protein expression by affecting Ubx transcriptional
Fig. 2. ELAV binds to discrete elements withinUbxRNAs. (A) Based on the
computational detection of RNA sequence elements with high similarity to
those present in other ELAV targets (Neuroglian, Nrg; erect wing, ewg) and
AU-rich elements (AREs) we determined that the Ubx locus contains at
least 16 putative binding sites for the neural protein ELAV. Phylogenetic
analysis of Ubx sequences within distantly related Drosophilids reveals that
a subset of ELAV putative binding sites (EBSs) (sites 3, 8, 13 and 16) have
been conserved for more than 60 million years of independent evolution
(i.e. ultraconserved), suggesting that they might be functionally relevant.
(B) UV cross-linking experiments reveal that Drosophila ELAV is able to bind
to discrete elements in Ubx mRNAs. A panel of radioactively labelled (32P)
RNA probes (top, see Input RNA gel), including elements from the ewgmRNA
(a previously described experimentally validated ELAV target) and the four
ultraconserved Ubx ELAV binding sites detected bioinformatically (sites 3, 8,
13 and 16), were incubated with ELAV protein and treated with RNase A,
with or without prior UV crosslinking (UV-CL; − or +) and the products of these
reactions were resolved by PAGE-SDS. These experiments revealed that
ELAV has high affinity for sites 3 and 8, but very low affinity for sites 13 and
16 (bottom left shows quantification of ELAV-bound RNA per UbxmRNA site).
Furthermore, site-specific mutagenesis affecting the core binding sequences
of ELAV in sites 3 and 8 led to a significant reduction in interaction between
ELAV and Ubx mRNAs (bottom right shows quantification of ELAV-bound
RNA per wild-type or mutated Ubx mRNA site). These experiments show
that ELAV is able to strongly interact with specific sites within Ubx mRNAs.
AS, antisense. (C-E) EMSAs using 32P-labelled Ubx and ewg RNAs further
confirms that ELAV has high affinity for Ubx sites 3 and 8 and that mutation of
these sites leads to a change in ELAV-RNA interaction. (C) RNA probes
were radioactively labelled and quantified so that equal molar units of each
type of RNA were included. ELAV forms a range of complexes as a result of
multimerisation on ewg probes (asterisks). Multimerisation is also observed
on Ubx probes (asterisks). Note that the amount of probe is not saturating,
therefore allowing us to estimate the affinity of ELAV protein for each RNA
probe by following the disappearance of ‘free RNA’ signal as a function of
the increase in ELAV protein concentration ([ELAV]) in the experiment: if
free RNA probe signal disappears at lower concentrations of ELAV then this
is an indication of higher affinity of ELAV for such RNA sequences as
compared with those for which ELAV concentration has to reach maximum
levels to generate shifted complexes. (D) Quantification of the binding
profiles of ELAV protein to ewg and UbxRNA probes as shown in C. (E) EMSA
using mutated versions of probes 3 and 8 shows reduced binding activity
(dashed rectangles) and a change in the range of protein-RNA complexes
formed. (F) RNA cross-linking and immunoprecipitation (RNA-CLIP) assay
using embryonic nuclear extracts shows that anti-ELAV antibodies are able to
precipitate RNA derived from ewg and Ubx sites 3 and 8. Altogether, these
experiments support the model that ELAV interacts directly with Ubx RNAs
via sequences in the ultraconserved sites EBS3 and EBS8. Error bars indicate
s.e.m. **P<0.01, ***P<0.001 [Wilcoxon matched-pairs signed rank test
(non-parametric t-test)].
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Fig. 3. ELAV removal leads to reduced
expression of UbxmRNA and protein and
promotes accumulation of nascent Ubx
RNA transcripts within the Drosophila
CNS. (A) Immunostaining of dissected
embryonic ventral nerve cords (anterior is to
the left) showing the expression of Ubx
protein in wild-type and homozygous elav
(elav5) mutant embryos at stage 16; elav5
mutant embryos express significantly lower
levels of Ubx protein within their CNS.
(B)Western blot analysis of latewild-type and
elav5 embryos shows that the spectrum of
Ubx protein isoforms produced in wild-type
and mutant embryos closely matches the
changes observed at the level of mRNA
(Fig. 1) and reveals that elav5 embryos
express overall lower levels of Ubx protein
than their wild-type counterparts. n=9 per
genotype; error bars indicate s.e.m.;
**P<0.01 [Wilcoxon matched-pairs signed
rank test (non-parametric t-test)]. (C) Profile
quantification of Ubx protein expression
along the AP axis (axial expression) as
shown in A (standard error is indicated by
grey shading). (D) Total Ubx mRNA levels
as detected by amplification of the constant
Ubx 50 exon region are significantly reduced
in elav5 embryos compared with wild type.
n=6 per genotype; error bars indicate s.e.m.;
*P<0.05 [Wilcoxon matched-pairs signed
rank test (non-parametric t-test)]. (E) Analysis
of Ubx transcriptional inputs in elav mutants
and wild-type embryos using the 35UZ
Ubx-lacZ promoter fusion. No appreciable
difference in Ubx-lacZ expression is detected
between wild-type and elav5 embryos.
(F) Ubx nascent transcript expression
detected by FISH using Ubx intronic probes
(intron 3) indicates that elav mutant embryos
show an overall higher signal in Ubx nascent
transcript foci. Inset shows Ubx signal
detected in two discrete nuclear foci (orange
arrowheads) per nucleus (blue, DAPI).
(G) Quantification of Ubx nascent transcript
expression in wild type and elav5 mutants
shows that the distributions of Ubx nascent
transcript foci [log(10)] versus voxel signal
intensity are substantially different among
genotypes. Best fit curves are shown. Plotting
either the relative number ofUbx foci (middle)
or relative intensity ofUbx foci (right) detected
in wild-type and elav mutant embryos further
confirms that elav5 mutants show an overall
higher level of expression of Ubx nascent
transcripts. n=7 per genotype; error bars
indicate s.e.m.; *P<0.05 [Wilcoxon matched-
pairs signed rank test (non-parametric
t-test)].
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rates, as this is a regulatory process known to affect the kinetics and
outcome of both AS and APA reactions (de la Mata et al., 2003;
Licatalosi and Darnell, 2010; Proudfoot, 2011).
To explore this possibility we first tested the total levels of Ubx
mRNAs produced in wild type and elav5 mutants and observed
that, indeed, elav mutant embryos show reduced levels of Ubx
mRNA (Fig. 3D). This finding led us to look more closely at the
levels of Ubx transcription in elav mutants. We first explored
the transcriptional activity of Ubx cis-regulatory regions using the
Ubx transcriptional reporter 35UZ (Irvine et al., 1991). This reporter
construct includes 35 kb of Ubx regulatory DNA linked to the lacZ
reporter and drives Ubx-like lacZ expression during embryogenesis
(Irvine et al., 1991). Contrary to our expectations, these experiments
showed no significant differences in Ubx transcriptional activity in
the presence and absence of ELAV (Fig. 3E), indicating that ELAV
effects on Ubx expression were likely to occur after transcriptional
initiation. Bearing this in mind, we then looked at the levels of Ubx
nascent transcripts in wild-type and elav5 embryos, developing a
series of fluorescence in situ hybridisation (FISH) experiments using
intronic probes so as to detect precursor RNAs rather than mature
mRNAs as visualised by standard RNA in situ hybridisation
(Fig. 3F). Remarkably, we found that in ≥70% of elav5 embryos
the abundance of Ubx nascent transcripts was significantly higher
than in their wild-type counterparts at an identical developmental
stage (Fig. 3F,G). Furthermore, applying an image segmentation and
quantification pipeline based on the Fiji imaging platform
(Schindelin et al., 2012) to nascent Ubx transcript signals detected
in elav5 and wild-type samples, we observed that elav5 embryos show
both a higher number of transcriptional foci (Fig. 3G, middle) and an
overall higher signal intensity level per focus (Fig. 3G, right).
Based on these experiments, we propose that the absence of ELAV
leads to inefficientUbx RNA processing and retention of RNA at the
site of transcription, with a consequential reduction in Ubx mRNA
release from DNA and lower Ubx protein formation, suggesting that
ELAV-dependentUbxRNAprocessing could ‘fine-tune’ the levels of
expression ofUbxwithin the nervous system. Thismodel is consistent
Fig. 4. ELAV regulation leads to changes in neural
subroutines under Ubx control. (A) The Drosophila
embryonic CNS is formed by a modular segmental array
of neuroblasts (left: ventral view of an early embryo,
dashed line marks midline; middle left: hemi-segmental
set of neuroblasts). Each neuroblast produces a specific
cell lineage exhibiting a stereotyped pattern of
differentiation. Neuroblast NB7-3 gives rise to six
postmitotic progeny cells of which two undergo
programmed cell death (crossed out) at early stages and
four differentiate into specific neuronal cell types
including GW (middle right; see colour code for molecular
markers at bottom). In the late embryo, GW undergoes
programmed cell death only in segments T3-A7 (see
right). (B-D) Confocal imaging of the NB7-3 cluster in
stage 16 embryos reveals that in wild-type conditions (B)
GW neurons undergo apoptosis specifically in the
posterior thorax (T3) and abdomen (A1-A7) (Dcp-1-
positive cells in segments T3 and A1, arrows).
(C) Notably, genetic removal of elav leads to a significant
reduction of GW apoptosis. (D) Artificial supply of Ubx
protein in elav5mutants restores normal apoptosis of GW
neurons in T3/A1-A7. (E) Quantification of apoptotic
behaviour of the GW neuron confirms that reduction of
ELAV expression leads to a marked decrease in GW
apoptosis [82.03% GW apoptosis in wild type (n=128)
versus 9.30% in elav5 (n=86)]; notably, restoring Ubx
protein expression in the system leads to rescue of the
apoptotic behaviour of GW. Interestingly, isoforms Ia and
IVa have significantly distinct (P<0.05, chi-squared test)
abilities to restore apoptosis [63.30% (n=109) versus
78.30% (n=106) GW apoptosis, respectively)],
suggesting thatUbx ASmight play a differential role in the
specification of GW apoptosis along the body axis.
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with our data and with previous reports on other systems (including
human beta-globin, glyceraldehyde 3-phosphate dehydrogenase,
ribosomal protein L3, DNA damage-inducible transcript 3)
indicating that non-canonical RNA processing reactions usually
prevent mRNA flow to the cytoplasm by tethering processedmRNAs
to DNA around transcription sites (Custodio et al., 1999, 2007;
Schwartz et al., 2012).
ELAV removal leads to respecification of neural
differentiation programmes under Ubx control
Having established the roles of ELAV in Ubx expression within the
CNS,we then explored further the biological consequences of ELAV-
regulated Hox expression during nervous system development,
focusing on the functions of Ubx during the establishment of
specific cellular programmes within the developing CNS. We
reasoned that if ELAV regulation of Ubx RNA processing and
protein expression were relevant to the biological functions of Ubx
during neural development then we should be able to find specific
cellular processes affected in elavmutants and these shouldbe reverted
byartificial provision ofUbx protein. To test these predictionswe used
a cellular system that had been shown to be sensitive to Ubx dosage:
the lineageNB7-3 (Fig. 4A).Here, variations inUbx expression lead to
a notable respecification of the apoptosis patterns of the NB7-3–
derived GW neuron (Rogulja-Ortmann et al., 2008). In particular,
reductions in Ubx expression, such as those observed in Ubx1
heterozygotes, lead to a decrease in the proportion of GW neurons
undergoing apoptosis in the posterior thorax and abdomen (Rogulja-
Ortmann et al., 2008). We examined to what extent the apoptosis
patterns in GW neurons were affected in elav mutants (Fig. 4B-E).
Quantification under confocal microscopy of the apoptosis patterns of
GWin over 400 neural hemisegments (stage 16) revealed that levels of
ELAV strongly influenced the apoptosis patterns of GW: genetic
removal of ELAV leads to a significant reduction in the levels of
apoptosis of GW in both thoracic and abdominal segments (Fig. 4E),
indicating that changes in the ELAV supply can respecify cellular
subroutines under Hox gene control within the developing CNS.
Similar effects on GW apoptosis were observed in elavts mutants (in
which expression of ELAV is reduced but not entirely abolished),
which show a clear reduction in GW apoptosis when compared with
wild-type embryos (supplementary material Fig. S1). In addition,
elavtsmutants display reduced levels of Ubx protein expression in the
CNS, confirming by means of an independent genetic context to
the elav5 mutation that reduction in ELAV supply determines a
reduction inUbx protein expression (supplementarymaterial Fig. S5).
Furthermore, the observed reduction in Ubx protein expression
level in elav5 mutants (Fig. 3) is fully consistent with the apoptotic
effects observed in NB7-3 in that a reduction of Ubx expression is
expected to reduce the level of GW apoptosis, exactly as observed
(Fig. 4B-E). Remarkably, when we restored expression of Ubx
mRNAs within the NB7-3 lineage in elav5 embryos we observed
normal apoptosis levels of GW (Fig. 4D,E), demonstrating that the
effects of ELAV on the cellular behaviour of GW are mediated by
Ubx. Interestingly, selective expression of distinct Ubx splicing
isoforms (i.e.Ubx Ia versusUbx IVa) in the elavmutant background
revealed isoform-specific roles of Ubx proteins in the rescue of GW
apoptosis patterns: Ubx Ia was significantly less efficient than Ubx
IVa in rescuing GW apoptosis. These observations suggest that
individual Ubx isoforms might play differential roles in neural
differentiation along the AP axis. In addition, the fact that Ubx
isoform Ia is less efficient than IVa in rescuing normal GWapoptosis
patterns provides another explanation for why GW apoptosis is
diminished in elav5 mutants: in the absence of ELAV the system
produces overall reduced levels of Ubx protein (Fig. 3A,C) and, in
addition, much of the protein formed is of the ‘wrong’ kind (i.e. high
Fig. 5. Artificial expression of ELAV promotes Ubx protein expression in glial cells. (A,C,E) Expression of Ubx nascent RNAs (nRNA, red) can be
detected (white arrows) in ∼30% of all glial cells (Repo, blue) across dorsal (top), medial (middle) and ventral (bottom) planes within T3 and abdominal
segments (not shown). Taking into account that Ubx protein expression is not seen in the glia (Miguel-Aliaga and Thor, 2004), these observations suggest
that Ubx protein expression is somehow inhibited in glial cells in which Ubx transcription is active. Grey arrows indicate Ubx transcribing cells in posterior or
anterior segments to T3. Approximate midline positions are indicated by a dashed line; please note that symmetry may not be apparent in these images due
to the thinness of confocal imaging. (B,D,F) Artificial expression of ELAV within the glial domain by means of repo-gal4 leads to an increase in Ubx protein
expression in Ubx transcribing cells (circled with dashed white lines) in the dorsal (B), medial (D) and ventral (F) glia suggesting that ELAV is sufficient to
stabilise Ubx protein expression in those glial cells in which Ubx transcription is normally active.
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Ubx Ia low Ubx IVa) to efficiently activate GW apoptosis.
Interestingly, similar effects on apoptosis were observed when
studying the role of ELAV in the apoptotic behaviour of MNa
neurons in the posterior thoracic segment (T3) (supplementary
material Fig. S4), which showed a clear reduction in apoptosis
compared with wild-type embryos. These cells are derived from
the NB2-4 lineage and their apoptosis profiles were previously
shown to rely on Ubx protein level (Rogulja-Ortmann et al., 2008).
All in all, our analysis here reveals that ELAVmodifies the outcome
of specific cellular subroutines under Hox control within the
Drosophila developing embryonic CNS.
Artificial expression of ELAV promotes Ubx protein
expression in glial cells
To further explore the biological roles of ELAV in Hox expression
within neural tissuewe considered the possibility that the absence of
ELAV from specific neural cell types (e.g. glial cells) could be
related or even contribute to the known lack of Hox protein
expression in such cells (Miguel-Aliaga and Thor, 2004). Indeed,
the fact that both ELAV and Hox genes are not expressed in the glia
could form the basis for an experimental approach to test this idea.
Based on the molecular functions of ELAV as an RBP primarily
involved in RNA processing and stability, and the fact that its
genetic removal does not affect Ubx transcription (Fig. 3E), we
reasoned that if ELAV had any effects on Hox protein expression in
the glia then such effects would only be expected in those glial cells
in which Ubx transcription was normally active. To determine
which glial cells (if any) could meet this proviso, we colabelled glial
cells (using anti-Repo antibodies) and nascent Ubx RNAs (nRNAs)
(making use of a combination of intronic Ubx probes) in late wild-
type embryos (Fig. 5A,C,E). These experiments revealed that the
majority of glial cells did not have an active Ubx transcriptional
programme. Indeed, in the posterior thoracic segment (T3), which is
one of the regions with highest expression of Ubx, only about
one-third of glial cells transcribes Ubx nRNAs, making it unlikely
that the absence of ELAV from glia could explain the general lack of
Hox expression in these cells.
However, detailed analysis of those cells in which Ubx nRNAs
could be detected did reveal that artificial expression of ELAV via
repo-gal4 could indeed promote the expression of Ubx protein:
forced expression of ELAV in dorsal (e.g. longitudinal glia;
Fig. 5B), medial (e.g. lateral cell body glia; Fig. 5D) and ventral
(e.g. medial ventral subperineurial glia; Fig. 5F) glial cells
resulted in the production of Ubx protein, which is normally not
formed in these cells. These experiments suggest that absence of
ELAV from glial cells might contribute to the lack of Ubx protein
expression in the fraction of these cells in which Ubx transcription
is normally active.
Effects of ELAV on the expression of other Hox proteins
Finally, we decided to investigate the generality of our observations
by testing whether ELAV was capable of exerting any effects on the
expression of other Hox genes within the nervous system.We looked
at the effects of ELAV removal on the other Hox genes within
the Drosophila Bithorax complex (BX-C), namely abdominal A
(abd-A) and Abdominal B (Abd-B) (Sánchez-Herrero et al., 1985),
given that these genes also display neural-specific patterns of
RNA processing (Thomsen et al., 2010). Immunostaining of late
embryos (late stage 16) using anti-Abd-A and anti-Abd-B antibodies
(Fig. 6A,B,D,E) established that expression of both Abd-A and
Abd-B proteins was markedly reduced when ELAV was genetically
removed, demonstrating that our observations concerning the effects
of ELAVonUbx expression reflected amore general case concerning
all Hox proteins encoded within the BX-C. Nonetheless, the
reduction in Ubx, Abd-A and Abd-B protein expression in
the absence of ELAV could also be explained by a potentially
pleiotropic effect of ELAV on neural gene expression: if ELAVwere
required for the normal expression and function of cellular
components involved in gene expression (e.g. ribosomal proteins)
then its removalwould be expected to impact the expression of a large
Fig. 6. The effects of ELAV removal on the expression of other Hox proteins than Ubx. (A-C) Comparison of expression levels of Abd-A protein in
dissected ventral nerve cords of wild type (A) and elav5 mutants (B) reveals that ELAV removal decreases the overall expression of Abd-A protein within the
embryonic CNS. (C) Average profile quantification of Abd-A protein along the AP axis of wild-type and elav5 embryos. (D-F) Expression levels of Abd-B
protein are much higher in wild-type (D) than in elav5 mutant (E) embryos, revealing that ELAV removal exerts similar effects across all protein-coding genes
within the BX-C. (F) Quantification of Abd-B protein expression in wild-type and elav5 mutant embryos. (G-I) The pattern and expression levels of Antp
protein are unaffected by ELAV removal. Antp protein expression levels in wild-type embryos (G) are comparable to those in elav5 mutant embryos
(H) indicating that the effects of ELAV on Hox protein expression within the CNS vary from gene to gene. (I) Quantification of Antp protein expression in
wild-type and elav5 embryos. (C,F,I) Grey shading represents standard error. (A,B,D,E,G,H) DAPI, blue.
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numberof genes, including theHoxgenes. Further experimentsmade
this possibility very unlikely, as the expression of another Hox gene,
Antennapedia (Antp), is unaffected by ELAV removal (Fig. 6G-I),
demonstrating that the effects of ELAV on BX-C genes are specific
and not the consequence of a general shutdownof protein synthesis in
neural tissue caused by the absence of ELAV.
DISCUSSION
Our work shows that the pan-neural RBP ELAV regulates Ubx
RNA processing, expression and function within the Drosophila
embryonic CNS, demonstrating that changes in ELAV level
respecify cellular subroutines under Ubx control. Based on these
findings we propose a model whereby the regulation of Hox gene
expression by RNA processing factors adapts the morphogenesis of
the nervous system according to axial level by specifically activating
local programmes of cell differentiation.
Our study also adds to the understanding of the biological roles of
ELAV/Hu by revealing that ELAV is part of the molecular
machinery underlying an intrinsic and highly specific programme
of cell death within the developing Drosophila CNS. This is, to our
knowledge, the first demonstration of a specific cellular role for this
neural protein. Based on the recent finding that ELAV controls the
formation of 30UTR extensions of several otherDrosophilamRNAs
(Hilgers et al., 2012), we envisage that our present findings are
likely to have revealed the first of a wider set of cellular functions
played by ELAV through the regulation of its targets in neural tissue.
The notion that the activation of particular patterns of Hox RNA
processing via RBPs such as ELAV/Hu can lead to significant
fluctuations in Hox protein expression in selected cellular
environments suggests the existence of a novel regulatory
framework whereby cellular decision making within neural tissue
could be adapted to axial level via specific RNA processing
programmes triggered and controlled by RNA regulatory factors.
At the molecular level, we interpret the changes observed in Ubx
RNA processing patterns in the absence of ELAV to represent the
outcome of those transcription/processing rounds that were
completed despite the absence of this crucial regulator of the
process. According to this view, the unavailability of ELAV, with the
consequential effects on normal Ubx RNA processing, leads to
the retention and accumulation of Ubx RNAs close to the site of
transcription. This interpretation is in line with previous work
suggesting that disruption of normal RNA processing reactions can
prevent mRNA flow to the cytoplasm by tethering of incompletely
processed RNAs to DNA around sites of transcription (Custodio
et al., 1999, 2007; Schwartz et al., 2012). We speculate that the cell
must have ways to determine, via a series of molecular devices,
whether a certain RNA processing pathway has been completed
successfully and, should this be not apparent, to trigger an appropriate
course of action that seeks to prevent potentially deleterious RNAs
from proceeding to export and translation.
Finally, taking into consideration that: (1) Hox genes are
evolutionarily conserved between insects and mammals; (2)
mammalian Hox genes are key developmental regulators of neural
differentiation and undergo substantial levels of RNA processing
(P.P. and C.R.A., unpublished); (3) ELAV/Hu RBPs are also
evolutionarily conserved between insects and mammals (Yao et al.,
1993); and (4) mutations in ELAV-like Hu proteins lead to various
forms of neural pathology in humans, we envisage that our findings in
Drosophila might be of general relevance for understanding the
molecular and cellular specification of Hox gene function during
the development of the mammalian nervous system.We are currently
testing this possibility in the mouse, in which the role of Hox genes
during neural specification, differentiation and connectivity has been
studied in great detail (Phillippidou and Dasen, 2013).
MATERIALS AND METHODS
Fly strains
Flies were cultured following standard procedures at 25°C on a 12 h light/dark
cycle. Oregon Red was used as a wild-type strain. The following mutant fly
strains were used: elav5 null mutant (Robinow and White, 1991) and
UAS-Elav2e2, UAS-Elav3e1 (both kindly provided by Matthias Soller,
University of Birmingham, UK), UAS-Apollinaire (Bardet et al., 2008),
elavts1 (Bloomington Stock Center), Act5c-GAL4 (a gift from Rob Ray,
UniversityofSussex,UK),Ubx-35UZ (Irvine et al., 1991),eagle-Gal4 (MZ360)
(Dittrich et al., 1997), UAS-UbxIa and UAS-UbxIVa (Reed et al., 2010).
Embryo collection, RNA isolation and RT-PCR
Embryos were collected using standard procedures. For in situ hybridisations
and antibody stainings, embryos were fixed following standard procedures.
For RT-PCR, total RNAwas extracted from staged embryo collections using
TRI Reagent (Sigma), followed by RNase-free DNaseI treatment (New
England BioLabs). Total RNA (1-2 μg) was used for cDNA synthesis using
random hexamer or oligo(dT) primers and MuLV reverse transcriptase
(Invitrogen). Expression values were normalised using RpL32 (Rp49). At
least three independent biological replicates were performed.
RNA in situ hybridisations
Embryos were fixed using standard protocols. Templates of RNA probes
for RNA in situ hybridisation were obtained from PCR-amplified genomic
fragments cloned into pGEM-T (Promega). RNA probes were labelled
using a digoxigenin (DIG) RNA Labelling Kit (SP6/T7; Roche) according
to the manufacturer’s instructions. Embryos were treated as described
(Beckervordersandforth et al., 2008) and hybridised with riboprobes
according to standard protocols. RNA probes were detected using anti-DIG-
AP (Roche; 1:2000) and a chromogenic reaction using NBT/BCIP substrate
(Roche). Enzymatic detection reactions with NBT/BCIP (Roche) were
carried out in parallel and stopped at exactly the same time for probes
targeting universal and distal 30UTR sequences to ensure comparability of
results. Fluorescent detection of RNA probes was performed using
anti-DIG-POD (Roche; 1:300) followed by FITC or Cy3 TSA Plus
Amplification Kit (PerkinElmer; 1:50). Subsequent imaging was performed
on a Zeiss Axiophot confocal microscope and the images were processed
using ImageJ and Adobe Photoshop.
Immunocytochemistry
Antibody stains were performed following standard procedures. Primary
antibodies were monoclonal mouse anti-Ubx (FP3.38, a gift from Robert
White, University of Cambridge; 1:20), mouse anti-Antp (4C3; 1:20), mouse
anti-Abd-B (1A2E9; 1:20), rat anti-ELAV (7E8410; 1:300) and mouse anti-
ELAV (9F8A9; 1:300) (all from Developmental Studies Hybridoma Bank);
goat anti-Abd-A (dH-17, Santa Cruz Biotechnology; 1:20); rabbit anti-Eg
(Dittrich et al., 1997; 1:500); mouse anti-Eg (a gift from Chris Doe,
University of Oregon, USA; 1:100); rabbit cleaved Drosophila Dcp-1
(Asp216, Cell Signaling; 1:50); guinea pig anti-Hb (J. Urban, University of
Mainz, Germany; 1:500), rabbit anti-β-gal (A11132, Molecular Probes;
1:300), rabbit anti-GFP (A6455, Molecular Probes; 1:300) and rabbit anti-
Repo (as described by Halter et al., 1995; 1:500). Secondary antibodies used
were anti-mouse-A488 (A21202; 1:500), anti-rat-A488 (A21202; 1:500) and
anti-rabbit-Alexa568 (A10042; 1:500) (all from Molecular Probes); anti-
rabbit-Rhodamine (711-025-152; 1:500), anti-rat-Rhodamine (712-026-153;
1:500), anti-guinea pig-Cy5 (706-175-148: 1:500), anti-rat-DyLight 405
(712-475-153; 1:500), anti-goat-Cy3 (705-165-003; 1:500) (all from Jackson
ImmunoResearch Laboratories).
Oligo in situ hybridisation
Embryos were fixed in 4% paraformaldehyde (PFA; freshly dissolved in
PBS):heptane (1:4) solution for 20 min. Following devitellinisation and
methanol washes, embryos were refixed in 4% PFA for 20 min.
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Permeabilisation was performed in 3 µg/ml Proteinase K solution for 13 min
at 22°C, followed by incubation on ice for 1 h. Proteinase K was inactivated
by washes in 2 mg/ml glycine in PBTween (PBS with 0.1% Tween 20) and
embryos refixed for 20 min in 4% PFA. Prehybridisation was carried out
overnight at 37°C. DIG-labelled oligo probes were hybridised for 1 day at
37°C, washed in hybridisation buffer at 40°C and in PBTween at room
temperature. For detection of oligo probes, embryos were incubated with
sheep anti-DIG-AP antibody (Roche) and stained for 20 h at 4°C using the
ABC Kit (Vectastain). After a series of washes, embryos were fixed in 4%
formaldehyde. For identification of elav5 mutant embryos, a rabbit anti-ß-
gal antibody was used (55976, MP Biomedicals; 1:1000). Embryos were
mounted and stored in 70% glycerol.
Bioinformatic search of ultraconserved ELAV targets
We scanned theUbx sequence ofDrosophila melanogaster for elements with
high similarity to experimentally validated EBSs present in the previously
reported ELAV target genes Neuroglian (Nrg, Nrg-like) (TTTTTGTTGT,
TTGTTTTTTT, TTTGTTTTT, TTTTATTTAT, TTTTTTTT) (Lisbin et al.,
2001) and erect wing (ewg, ewg-like) (AAUUUUUU, CAUUUUUU)
(Soller and White, 2003). To explore the evolutionary conservation of these
elements across related Drosophila species we retrieved the sequences
corresponding to the full Ubx transcription unit from the 12 fully sequenced
drosophilids from the UCSC Genome Browser (D. melanogaster,
D. simulans, D. sechellia, D. yakuba, D. erecta, D. ananassae, D.
pseudoobscura, D. persimilis, D. willistoni, D. mojavensis, D. virilis, D.
grimshawi) and confirmed their identity as Ubx-encoding sequences using
BLAST. Ubx sequences derived from different Drosophila species were
then aligned using the mVISTA LAGAN algorithm (Brudno et al., 2003).
We defined as putative ELAV binding sites (pEBSs) all those elements that:
(1) presented an exact match to those present in Nrg and ewg and (2) were
evolutionarily conserved in a homologous position across eight or more of
the 12 drosophilid species (i.e. ultraconserved). In addition to sequence
elements similar to those present in Nrg and ewg RNAs, we also included in
our list of Ubx pEBSs a previously described AU-rich element (ARE)
present in the 30UTR of D. melanogaster Ubx (Cairrao et al., 2009) given
that AREs were shown to be crucial regulators of RNA metabolism through
binding of Hu proteins (López de Silanes et al., 2004). All 16 pEBSs are
presented in supplementary material Fig. S3.
Site-specific mutation of the putative ELAV binding sequences contained
within EBS3 and EBS8 (site 3 WT, ATTTTTT; site 3 Mut, AGTGTGT;
site 8A WT, TTTTTGTTT; site 8A Mut, TGTGTGTTT; site 8B WT,
TTTGTTTT; site 8BMut, TGTGTGTG), as used in EMSA, was carried out
by DpnI-mediated site-directed mutagenesis.
EMSA experiments
Recombinant GST-ELAV protein was produced in E. coli using an
expression vector kindly provided by Matthias Soller (described in Soller
and White, 2003) following the manufacturer’s instructions (Amersham).
GST tag was cleaved with PreScission Protease (Amersham). EMSA
experiments were performed as described by Soller and White (Soller and
White, 2003). In brief, gel purified ‘body’ labelled RNA was incubated
with tRNA (50 μg/ml) at 65°C for 5 min, renatured at room temperature
for 10 min and then mixed with binding buffer (50 mM Tris-HCl pH 7.5,
40 mMKCl, 35 mMNaCl, 25 μg/ml tRNA, 0.5 mMDTT, 50 μg/ml BSA)
in a total of 10 μl, and incubated at room temperature for 20 min with
either 0, 200, 400 or 600 mM ELAV protein. Ten microlitres reaction with
3 μl 50% glycerol were loaded on 4% (80:1 acrylamide/bisacrylamide)
polyacrylamide native gels and run at room temperature at 250 V in
0.5×TBE. Gels were dried and exposed to phosphorimager plates.
UV cross-linking experiments
Uniformly labelled RNA (typically 700 pM) was incubated in 5× binding
buffer (400 mM KCl, 100 mM HEPES pH 7.6, 20 mM MgCl2, 25%
glycerol and 5 mM DTT), 1 µl tRNA (1 mg/ml) and 38 µg/µl ELAV
protein or 40% nuclear extract in 10 µl total volume. The mix was
incubated at room temperature for 10 min and then divided into two
samples, one of which was subsequently UV cross-linked (Stratalinker)
for 12 min on ice whereas the other (negative control) was kept on ice in
the absence of UV. Samples were then treated with RNaseA at 37°C for
15 min. Reaction products were resolved by SDS-PAGE and dried gels
were exposed to phosphorimager plates.
Cross-linking and immunoprecipitation (CLIP) experiments
Immunoprecipitation of nuclear extracts from an overnight collection of
embryos was performed following the RNA immunoprecipitation protocol
of Hilgers et al. (Hilgers et al., 2012), except that the nuclear extracts were
incubated overnight with 2 μg mouse anti-ELAV 9F8A9 or mouse anti-Tub
E7 antibodies (Developmental Studies Hybridoma Bank).
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